JP4806162B2 - 爪の成長の機能障害および疾患を治療するための硬膏 - Google Patents

爪の成長の機能障害および疾患を治療するための硬膏 Download PDF

Info

Publication number
JP4806162B2
JP4806162B2 JP2003524559A JP2003524559A JP4806162B2 JP 4806162 B2 JP4806162 B2 JP 4806162B2 JP 2003524559 A JP2003524559 A JP 2003524559A JP 2003524559 A JP2003524559 A JP 2003524559A JP 4806162 B2 JP4806162 B2 JP 4806162B2
Authority
JP
Japan
Prior art keywords
nail
contact layer
plaster
adhesive
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003524559A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005501885A (ja
Inventor
スシロ，リューディ
Original Assignee
トロムスドルフ ゲーエムベーハー ウント コンパニー カーゲー アルツナイミッテル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by トロムスドルフ ゲーエムベーハー ウント コンパニー カーゲー アルツナイミッテル filed Critical トロムスドルフ ゲーエムベーハー ウント コンパニー カーゲー アルツナイミッテル
Publication of JP2005501885A publication Critical patent/JP2005501885A/ja
Application granted granted Critical
Publication of JP4806162B2 publication Critical patent/JP4806162B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003524559A 2001-09-04 2002-09-04 爪の成長の機能障害および疾患を治療するための硬膏 Expired - Fee Related JP4806162B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01121202 2001-09-04
EP01121202.4 2001-09-04
PCT/EP2002/009912 WO2003020250A1 (en) 2001-09-04 2002-09-04 Plaster for the treatment of dysfunctions and disorders of nail growth

Publications (2)

Publication Number Publication Date
JP2005501885A JP2005501885A (ja) 2005-01-20
JP4806162B2 true JP4806162B2 (ja) 2011-11-02

Family

ID=8178546

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003524559A Expired - Fee Related JP4806162B2 (ja) 2001-09-04 2002-09-04 爪の成長の機能障害および疾患を治療するための硬膏

Country Status (22)

Country Link
US (1) US20040265362A1 (cs)
EP (1) EP1423102B1 (cs)
JP (1) JP4806162B2 (cs)
KR (1) KR100757611B1 (cs)
CN (1) CN1703206A (cs)
AU (1) AU2002361825B2 (cs)
BR (1) BR0212304A (cs)
CA (1) CA2459483C (cs)
CY (1) CY1107284T1 (cs)
CZ (1) CZ301310B6 (cs)
DE (1) DE60223694T2 (cs)
DK (1) DK1423102T3 (cs)
ES (1) ES2299630T3 (cs)
IL (2) IL160550A0 (cs)
MX (1) MXPA04001833A (cs)
NO (1) NO20040936L (cs)
NZ (1) NZ531406A (cs)
PL (1) PL205576B1 (cs)
PT (1) PT1423102E (cs)
RU (1) RU2302857C2 (cs)
WO (1) WO2003020250A1 (cs)
ZA (1) ZA200401445B (cs)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615238B2 (en) * 2001-09-04 2009-11-10 Trommsdorff GmbH & Co. KG Arzneimitttel Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
EP1423102B1 (en) * 2001-09-04 2007-11-21 Trommsdorff GmbH & Co.KG Arzneimittel Plaster for the treatment of dysfunctions and disorders of nail growth
FR2867978B1 (fr) * 2004-03-29 2009-02-20 Galderma Res & Dev Patch d'amorolfine pour le traitement de l'onychomicose
JP4992181B2 (ja) * 2004-12-28 2012-08-08 大正製薬株式会社 外用剤組成物
US9168216B2 (en) 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
EP2057988B1 (en) * 2006-08-28 2013-09-11 Hisamitsu Pharmaceutical Co., Inc. Nail patch
WO2008105038A1 (ja) * 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤
EP3441054B1 (en) * 2007-11-05 2020-08-05 Abigo Medical Ab Device for the treatment of vaginal fungal infection
US8263115B2 (en) * 2008-09-11 2012-09-11 Abigo Medical Ab Method and a product to reduce and treat problems associated with tinea pedis
US10893983B2 (en) 2008-12-03 2021-01-19 Abigo Medical Ab Method for dressing a wound
CN102770123A (zh) 2009-12-23 2012-11-07 纽沃研究股份有限公司 用于治疗甲癣的高渗透性特比萘芬制剂
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
WO2011096566A1 (ja) 2010-02-05 2011-08-11 久光製薬株式会社 爪白癬治療用貼付剤
EP2547323B1 (en) 2010-03-17 2016-01-27 Novaliq GmbH Pharmaceutical composition for treatment of increased intraocular pressure
BR112012024835A2 (pt) * 2010-03-30 2016-06-07 Phosphagenics Ltd adesivo de distribuição transdérmica
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
RU2483748C2 (ru) * 2011-04-15 2013-06-10 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде пластыря
RU2483749C2 (ru) * 2011-04-15 2013-06-10 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде биопленки
EP2714008B1 (en) * 2011-05-25 2016-12-14 Novaliq GmbH Pharmaceutical composition for administration to nails
CA2834855C (en) 2011-05-25 2020-12-29 Novaliq Gmbh Topical pharmaceutical composition based on semifluorinated alkanes
DK2806886T3 (en) 2012-01-23 2017-06-06 Novaliq Gmbh STABILIZED PROTEIN COMPOSITIONS BASED ON SEMIFLUORED ALKANES
AU2013314303B2 (en) 2012-09-12 2018-01-18 Novaliq Gmbh Semifluorinated alkane compositions
MX363182B (es) 2012-09-12 2019-03-13 Novaliq Gmbh Composiciones que comprenden mezclas de alcanos semifluorados.
JP6503349B2 (ja) 2013-07-23 2019-04-17 ノバリック ゲーエムベーハー 安定化された抗体組成物
EP3495023B1 (en) 2015-09-30 2020-04-22 Novaliq GmbH Semifluorinated compounds and their compositions
US11154513B2 (en) 2015-09-30 2021-10-26 Novaliq Gmbh Semifluorinated compounds
EP3383371B1 (en) 2015-12-09 2024-05-01 Avecho Biotechnology Limited Pharmaceutical formulation
WO2017220625A1 (en) 2016-06-23 2017-12-28 Novaliq Gmbh Topical administration method
EP3515420B1 (en) 2016-09-22 2023-11-08 Novaliq GmbH Pharmaceutical compositions for use in the therapy of blepharitis
KR20190057338A (ko) 2016-09-23 2019-05-28 노바리크 게엠베하 시클로스포린을 포함하는 안과 조성물
CA3045702A1 (en) 2016-12-21 2018-06-28 Phosphagenics Limited Phosphorylation process of complex alcohols
AU2018253944B2 (en) 2017-04-21 2022-09-15 Dermaliq Therapeutics, Inc. Iodine compositions
EP3621601A1 (en) 2017-05-12 2020-03-18 Novaliq GmbH Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
US11723861B2 (en) 2017-09-27 2023-08-15 Novaliq Gmbh Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
US11896559B2 (en) 2017-10-04 2024-02-13 Novaliq Gmbh Opthalmic compositions comprising F6H8
WO2019166631A1 (en) 2018-03-02 2019-09-06 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
DE102018115270B4 (de) * 2018-06-26 2022-07-14 Vinederm GmbH Zubereitung als Gel und Pflaster zur topischen Behandlung von Haut- und/oder Nagelerkrankungen
CA3111870C (en) 2018-09-27 2022-04-12 Novaliq Gmbh Topical sunscreen formulation
ES2974839T3 (es) 2018-10-12 2024-07-01 Novaliq Gmbh Composición oftálmica para el tratamiento de la enfermedad de ojos secos
RU2717086C1 (ru) * 2019-01-31 2020-03-18 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Способ получения основы для пластырей и гелей (варианты)
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5181914A (en) * 1988-08-22 1993-01-26 Zook Gerald P Medicating device for nails and adjacent tissue
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
AU4449497A (en) * 1996-10-16 1998-05-11 Ipr-Institute For Pharmaceutical Research Ag New carrier systems
US6727401B1 (en) * 1998-02-12 2004-04-27 Watson Pharmaceuticals, Inc. Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
AU5404399A (en) * 1998-09-10 2000-04-03 Ipr-Institute For Pharmaceutical Research Ag Topical application products
US6303140B1 (en) * 1999-10-13 2001-10-16 Schering-Plough Healthcare Products, Inc. Medicated device for warts, corns, calluses and nails
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
EP1423102B1 (en) * 2001-09-04 2007-11-21 Trommsdorff GmbH & Co.KG Arzneimittel Plaster for the treatment of dysfunctions and disorders of nail growth

Also Published As

Publication number Publication date
CA2459483A1 (en) 2003-03-13
PL205576B1 (pl) 2010-05-31
CY1107284T1 (el) 2012-11-21
EP1423102B1 (en) 2007-11-21
RU2004106780A (ru) 2005-04-20
KR100757611B1 (ko) 2007-09-10
BR0212304A (pt) 2004-10-13
CZ2004317A3 (cs) 2004-10-13
PL367513A1 (en) 2005-02-21
DE60223694D1 (de) 2008-01-03
KR20040031046A (ko) 2004-04-09
ES2299630T3 (es) 2008-06-01
US20040265362A1 (en) 2004-12-30
JP2005501885A (ja) 2005-01-20
CZ301310B6 (cs) 2010-01-13
IL160550A0 (en) 2004-07-25
PT1423102E (pt) 2008-02-25
NZ531406A (en) 2006-03-31
NO20040936D0 (no) 2004-03-03
DE60223694T2 (de) 2008-10-30
CA2459483C (en) 2009-06-23
CN1703206A (zh) 2005-11-30
DK1423102T3 (da) 2008-04-14
AU2002361825B2 (en) 2007-01-25
EP1423102A1 (en) 2004-06-02
MXPA04001833A (es) 2004-07-08
RU2302857C2 (ru) 2007-07-20
ZA200401445B (en) 2005-03-10
IL160550A (en) 2010-11-30
WO2003020250A1 (en) 2003-03-13
NO20040936L (no) 2004-06-04

Similar Documents

Publication Publication Date Title
JP4806162B2 (ja) 爪の成長の機能障害および疾患を治療するための硬膏
AU2002361825A1 (en) Plaster for the treatment of dysfunctions and disorders of nail growth
JP2005501883A (ja) セルタコナゾールを含む爪の機能障害および疾患の治療用の膏薬
JP4262599B2 (ja) 爪の機能障害や疾患の治療用の膏薬
AU2002339494A1 (en) Plaster for the treatment of dysfunctions and disorders of nails
US7615238B2 (en) Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
ES2360482T3 (es) Uso de un emplasto para el tratamiento de la onicomicosis.
US20040258739A1 (en) Plaster for the treatment of dysfunctions and disorders of nails

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080408

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080707

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080819

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110704

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110812

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140819

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees